Central Role of Nuclear Medicine in Personalised Medicine

• 22/05/2023

Molecular radionuclide imaging and therapies have a central role in the management of some oncological diseases, in particular they find a central application in neuroendocrine tumours (NETs). Peptide receptor imaging is a fundamental part of the tumour staging, preoperative imaging, therapy selection and restaging. Using the same drug, labelled with a different radionuclide, it’s possible to offer...